Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
flutamide (eulexin) (1 trial)
triptorelin (Trelstar) (1 trial)
Prostatic Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)